2-methyl AP-237 (hydrochloride)
![]() |
- $81 - $495
- Product name: 2-methyl AP-237 (hydrochloride)
- CAS: 98608-59-4
- MF: C18H27ClN2O
- MW: 322.88
- EINECS:
- MDL Number:
- Synonyms:2-methyl AP-237 (hydrochloride);N-Butyryl-N'-cinnamyl-2-methylpiperazine Hydrochloride;1-[2-methyl-4-(3-phenyl-2-propen-1-yl)-1-piperazinyl]-1-butanone, monohydrochloride
4 prices
Selected condition:
Brand
- AK Scientific
- Cayman Chemical
Package
- 1mg
- 5mg
- ManufacturerAK Scientific
- Product number8714CP
- Product descriptionN-Butyryl-N'-cinnamyl-2-methylpiperazinehydrochloride
- Packaging1mg
- Price$187
- Updated2021-12-16
- Buy
- ManufacturerAK Scientific
- Product number8714CP
- Product descriptionN-Butyryl-N'-cinnamyl-2-methylpiperazinehydrochloride
- Packaging5mg
- Price$495
- Updated2021-12-16
- Buy
- ManufacturerCayman Chemical
- Product number26485
- Product description2-methyl AP-237 (hydrochloride)
- Packaging1mg
- Price$81
- Updated2024-03-01
- Buy
- ManufacturerCayman Chemical
- Product number26485
- Product description2-methyl AP-237 (hydrochloride)
- Packaging5mg
- Price$356
- Updated2024-03-01
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 8714CP | N-Butyryl-N'-cinnamyl-2-methylpiperazinehydrochloride | 1mg | $187 | 2021-12-16 | Buy |
AK Scientific | 8714CP | N-Butyryl-N'-cinnamyl-2-methylpiperazinehydrochloride | 5mg | $495 | 2021-12-16 | Buy |
Cayman Chemical | 26485 | 2-methyl AP-237 (hydrochloride) | 1mg | $81 | 2024-03-01 | Buy |
Cayman Chemical | 26485 | 2-methyl AP-237 (hydrochloride) | 5mg | $356 | 2024-03-01 | Buy |
Properties
solubility :DMF: 10 mg/mL; DMSO: 15 mg/mL; Ethanol: 30 mg/mL; PBS (pH 7.2): 10 mg/mL
form :A crystalline solid
form :A crystalline solid
Safety Information
Symbol(GHS): |
![]() |
||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | ||||||||||||||||||||||||
Hazard statements: |
|
||||||||||||||||||||||||
Precautionary statements: |
|